Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Express Scripts
Chubb
Harvard Business School
Daiichi Sankyo
QuintilesIMS
Citi
Boehringer Ingelheim

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087122

« Back to Dashboard

NDA 087122 describes METHDILAZINE HYDROCHLORIDE, which is a drug marketed by Alpharma Us Pharms and is included in one NDA. Additional details are available on the METHDILAZINE HYDROCHLORIDE profile page.

The generic ingredient in METHDILAZINE HYDROCHLORIDE is methdilazine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the methdilazine hydrochloride profile page.
Summary for 087122
Tradename:METHDILAZINE HYDROCHLORIDE
Applicant:Alpharma Us Pharms
Ingredient:methdilazine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SYRUP;ORALStrength4MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fish and Richardson
Argus Health
Fuji
US Department of Justice
Express Scripts
Accenture
Chinese Patent Office
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.